| Application no. and date | 17841965.1 (espacenet) (Federated) (European Patent Register), 20170815 | | Patent/reg. no. and date | DK/EP 3500301, 20230830 | | Publication date | 20190626 | | Priority no. and date | WO PCT/CN2016/009554, 20160816, WO PCT/CN2016/095546, 20160816, WO PCT/CN2016/010926, 20161209, WO PCT/CN2016/109267, 20161209 | | EP pub. no. and date |
EP 3500301 20190626 | | Effective date | | | Applicant/owner | Epimab Biotherapeutics Inc., 6th Floor, Building 2
4560 Jinke Road
Pudong New District
Shanghai 201112, CN | | Applicant ref. no. | V465262DK00 | | Inventor | WU, Chengbin, 56
1335 Pu Chi Road
Shanghai 201112, CN | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 51/10 (2006.01) , C07K 16/14 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) , A61P 17/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | Bispecifikke monovalente asymmetriske tandem-Fab-antistoffer | | Int. application no. | US2017046875 | | Int. publication no. | WO2018035084 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
